EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Guiding Light for Prevention: How International Lynch Syndrome Awareness Day Serves as a Satellite of Hope for the Romanian Population

Oana Voinea, Lucian Eftimie, Adrian Dumitru, Maria Sajin, Teodor Constantin

Romanian Journal of Preventive Medicine · 2023

DOI: 10.3390/rjpm2010018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Preventive Medicine, 2023. Verfasst von Oana Voinea und 4 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lynch syndrome, formerly known as Hereditary Non-Polyposis Colorectal Cancer (HNPCC), characterized by a defective DNA mismatch repair, is the most common autosomal dominant hereditary predisposition to several malignancies. LS patients typically exhibit an elevated risk of developing multiple primary malignancies with early onset. The most commonly involved organs are those with an accelerated cellular turnover. The colon and endometrium are the most commonly affected sites, however, the spectrum of neoplastic involvement extends beyond these organs and can involve the entire digestive tract, ovarium, urothelium, skin, and breast with varying incidences depending on the specific pathogenic variants affecting the MMR genes (MLH1, MSH2, MSH6, PMS2 and EPCAM). A conservative estimate suggests that the prevalence of mutations associated with Lynch syndrome in the general populations is 1 in 279 individuals. Over the last 25 years, significant advancements have been achieved comprehending the biology of cancers related to Lynch syndrome, alongside developing strategies for cancer prevention, risk mitigation, and targeted therapies. In Western countries, advancement in medical research and practice have led to the establishment of national programs that offer comprehensive approaches to diagnosis, screening, and targeted treatment options for Lynch syndrome patients.Romania lacks an oncogenetic program, which means that this disease, despite its personal and familial impact, remains opportunistically diagnosed. It is the most prevalent hereditary autosomal disease with oncological manifestations and yet no screening programs or targeted treatment protocols are available for Romanian patients with Lynch Syndrome.The Romanian healthcare system needs to align with the oncogenetics models of the Western world, which provide tailored screening and treatment programs for patients and their families. This article underlines the international position regarding prophylactic measures, diagnostic and treatment programs for Lynch syndrome and aims to motivate Romanian healthcare professionals to take action.

Zitieren

APA

Voinea, O., Eftimie, L., Dumitru, A., Sajin, M., & Constantin, T. (2023). A Guiding Light for Prevention: How International Lynch Syndrome Awareness Day Serves as a Satellite of Hope for the Romanian Population. Romanian Journal of Preventive Medicine. https://doi.org/10.3390/rjpm2010018

Vancouver

Voinea O, Eftimie L, Dumitru A, Sajin M, Constantin T. A Guiding Light for Prevention: How International Lynch Syndrome Awareness Day Serves as a Satellite of Hope for the Romanian Population. Romanian Journal of Preventive Medicine. 2023. doi:10.3390/rjpm2010018

BibTeX
@article{Voinea2023,
  author = {Voinea, Oana and Eftimie, Lucian and Dumitru, Adrian and Sajin, Maria and Constantin, Teodor},
  title = {A Guiding Light for Prevention: How International Lynch Syndrome Awareness Day Serves as a Satellite of Hope for the Romanian Population},
  journal = {Romanian Journal of Preventive Medicine},
  year = {2023},
  doi = {10.3390/rjpm2010018}
}
Kostenlos starten →